RANK is an independent biomarker of poor prognosis in estrogen receptor-negative breast cancer and a therapeutic target in patient-derived xenograftsMarina Ciscar, Eva González‐Suárez|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 0